Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Venture Funding Deals: Tenaya's $92m, Nuvation's $275m Lead October Rounds

Nov 08 2019

• By Deanna Kamienski, Beth Allan, and Maureen Riordan

Venture Funding Reg column image

Related Content

Tenaya, With $92m Financing, Aims To Win In Cardiology With Three Platforms

Oct 03 2019

Abalos Raises €12M Series A To Develop Arenavirus-Based Cancer Therapies

Oct 15 2019

Finance Watch: 3Q Biopharma Venture Capital Financings Fell From 2Q Spike

Oct 10 2019

AI Firm Healx Raises $56M To Develop Affordable Rare Disease Treatments

Oct 16 2019

David Hung Launches Start-Up Nuvation With Old Medivation Team And $275m

Oct 29 2019

Related Companies

Abalos Therapeutics GmbH

Adicet Bio Inc.

Regeneron Pharmaceuticals, Inc.

Aeovian Pharmaceuticals, Inc.

Evotec SE

Buck Institute for Research on Aging

Biotica Technology Limited

Pfizer Inc.

Arcellx, Inc.

Edgewise Therapeutics, Inc.

Healx

Icosavax, Inc.

US Department of Health and Human Services

University of Washington

University of Colorado

MiroBio

University of Oxford

Mogrify, Ltd.

University of Bristol

Nuvation Bio, Inc.

Roivant Sciences Ltd.

Sio Gene Therapies, Inc.

Shine Medical Technologies Inc

Tenaya Therapeutics, Inc.

Verseau Therapeutics, Inc.

3SBio Inc.

Aptargroup, Inc.

Medivation, Inc.

Additional Topics

Deals Financing StartUps and SMEs Business Strategies Commercial BioPharmaceutical

More from Deals

More from Business

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window